AI Verdict
AMZN has stronger fundamentals based on our AI analysis.
EMED vs AMZN Fundamental Comparison
| Metric | EMED | AMZN |
|---|---|---|
| Revenue | $570,415.0 | $716.9B |
| Net Income | $-1.3M | $77.7B |
| Net Margin | -233.1% | 10.8% |
| ROE | N/A | 18.9% |
| ROA | -233.8% | 9.5% |
| Current Ratio | 0.07x | 1.05x |
| Debt/Equity | N/A | 0.17x |
| EPS | $0.00 | $7.17 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EMED vs AMZN: Frequently Asked Questions
Is EMED or AMZN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMZN has stronger fundamentals. EMED is rated STRONG SELL (95% confidence) while AMZN is rated BUY (81% confidence). This is not investment advice.
How does EMED compare to AMZN fundamentally?
Electromedical Technologies, Inc has ROE of N/A vs AMAZON COM INC's 18.9%. Net margins are -233.1% vs 10.8% respectively.
Which stock pays higher dividends, EMED or AMZN?
EMED has a dividend yield of N/A or no dividend while AMZN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EMED or AMZN for long term?
For long-term investing, consider that EMED has STRONG SELL rating with 95% confidence, while AMZN has BUY rating with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EMED vs AMZN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EMED vs AMZN, the AI consensus favors AMZN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.